iShares Russell 2000 BuyWrite ETF (NY:IWMW)

37.85 +0.20 (+0.53%)

Delayed Quote Updated: 1:42 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares Russell 2000 BuyWrite ETF

< Previous 1 2 3 4 5 Next >

LUMN Stock Climbs 5% Pre-Market – What’s The Anthropic Connection? ↗

February 25, 2026

The company outlined several multi-year financial goals, including expansion of EBITDA margins to the mid-30% range by 2030.

Via Stocktwits

Topics Artificial Intelligence

IONQ Stock Tumbles 10% As Wolfpack Reveals Short Position ↗

February 04, 2026

Via Stocktwits

Why Is TeraWulf Stock Rallying More Than 10% After Hours? ↗

February 02, 2026

With the addition of these sites, TeraWulf’s infrastructure portfolio now totals approximately 2.8 GW across five sites.

Via Stocktwits

Immunitybio Initiates Another Cell Therapy Trial With No Chemotherapy Needs ↗

February 02, 2026

Via Stocktwits

PLX Shares Jump 13% On EMA Committee’s Turnaround On New Dosing Regimen For Fabry Disease Therapy ↗

January 30, 2026

Via Stocktwits

Peloton Reportedly Lays Off 11% Workforce ↗

January 30, 2026

Via Stocktwits

RGNX Shares Pare Losses As Wall Street Dismisses Gene Therapy Clinical Hold Spurred Selloff As An Overreaction ↗

January 28, 2026

Via Stocktwits

Bumble Chief Product Officer Reportedly Exits Amid Dating Platform’s ‘Return To Growth’ Efforts ↗

January 21, 2026

Via Stocktwits

VITL Shares Slip 6% On Health Concerns Around Eggs: Analyst Dismisses ‘Misleading’ Information, Reiterates ‘Buy’ Rating ↗

January 20, 2026

Via Stocktwits

USA Rare Earth Rallies More than 11% - What’s Driving The Optimism? ↗

January 20, 2026

Via Stocktwits

KRRO Shares Jump 13% On Analyst Upgrades — What’s Driving The Optimism? ↗

January 29, 2026

The company said on Tuesday that it intends to file an application in the second half of 2026 to begin its first in-human trial for its new development candidate KRRO-121.

Via Stocktwits

Bloom Energy Shares Surge – Why Are Analysts Initiating Coverage On The Stock? ↗

January 28, 2026

Brokerages like Barclays and China Renaissance initiated coverage on Bloom Energy.

Via Stocktwits

LUNR Shares Edge Up 3% After Hours — What's Intuitive’s Role In NASA’s Artemis Program? ↗

January 26, 2026

Intuitive is now part of 34 global volunteers chosen by the agency to track Artemis II.

Via Stocktwits

IOVA Shares Jump 8% — What’s Retail Expecting? ↗

January 26, 2026

Iovance is a commercial stage immuno-oncology company seeking to deliver tumor infiltrating lymphocyte (TIL) therapies for patients with cancer.

Via Stocktwits

Sable Offshore Plunged 14% Today – What Is The Feud With California State? ↗

January 23, 2026

California Attorney General Rob Bonta on Friday filed a lawsuit against the Trump Administration, challenging the Pipeline and Hazardous Materials Safety Administration’s (PHMSA) orders of allowing...

Via Stocktwits

Topics Government Lawsuit

IBRX Stock Extends Rally On FDA Feedback For ANKTIVA Bladder Cancer Filing ↗

January 20, 2026

Via Stocktwits

IBRX Stock Continues Rally — What’s Driving The Optimism Today? ↗

January 15, 2026

Via Stocktwits

Bakkt Stock Rallies Nearly 20% - What’s Behind The Move? ↗

January 12, 2026

Via Stocktwits

Why This Small-Cap Penny Stock Is Rallying Today – Traders Expect Stock Price To Double ↗

January 23, 2026

United States Antimony earlier in the week announced the closing of a property acquisition of a critical minerals flotation facility.

Via Stocktwits

ALT Stock Rallies 4% — What Does Retail Think? ↗

January 22, 2026

Earlier this month, Altimmune said the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for pemvidutide for the treatment of patients with metabolic...

Via Stocktwits

BigBear.ai Shares Tumble 8% Ahead Of Crucial Shareholder Vote Deadline On Increasing Authorized Shares ↗

January 21, 2026

The company wants its investors to approve an amendment for increasing its authorized common shares from 500 million to 1 billion shares.

Via Stocktwits

Topics Artificial Intelligence

CAPR Stock Slides After FDA Requests More Data For Genetic Disorder Therapy — What Does Retail Think? ↗

January 20, 2026

The FDA has formally requested the full HOPE-3 clinical study report (CSR) and supporting data, Capricor said on Tuesday.

Via Stocktwits

SELLAS Life Sciences Falls For Fourth Straight Session — What’s Driving The Sell Off? ↗

January 09, 2026

Via Stocktwits

RYTM Stock Jumps 4% On Imcivree Revenue Growth: Firm Awaits Approval In Acquired Hypothalamic Obesity By March ↗

January 09, 2026

Via Stocktwits

MannKind Rallies On Optimism Of Two Imminent Product Launches: Analyst Sees ‘Multiple Headwinds’ For Stock In 2026 ↗

January 08, 2026

Via Stocktwits

TGTX Rallies 7% After Hours On Revenue Estimates Based On Strong Briumvi Demand Through 2026 ↗

January 13, 2026

The company expects total revenue for full year 2025 to be about $616 million, including $594 million from sales of its Briumvi in the U.S.

Via Stocktwits

Topics Artificial Intelligence

KalVista Pharmaceuticals Stock Rallies After Hours On Strong Genetic Disorder Drug Sales Kickstart ↗

January 08, 2026

Ekterly is the first and only oral on-demand treatment for HAE, KalVista said, setting it apart from other on-demand HAE treatment options approved in the U.S.

Via Stocktwits

Ardelyx Stock Is Rallying – What Is Making Retail So Bullish? ↗

January 08, 2026

The company said it made significant commercial progress in 2025, generating approximately $378 million in product revenue.

Via Stocktwits

ELVN Stock Shot Up 60% Today – What’s Driving The Rally? ↗

January 08, 2026

The company reported positive initial data from its ongoing Phase 1b clinical trial evaluating ELVN-001 in patients with chronic myeloid leukemia.

Via Stocktwits

Joby Inks $61.5 Million Deal To Acquire Another Ready-To-Use Facility In Ohio As It Eyes Doubling eVTOL Production ↗

January 07, 2026

The new facility spans more than 700,000 feet and is ready for immediate use, the California-based company said.

Via Stocktwits

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.